Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
1 study found for:    22814329 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed
Has Results
Oral Posaconazole Three Times Per Day vs Weekly High Dose Amphotericin B Lipid Complex (ABLC)
Conditions: Invasive Fungal Infections;   Hematologic Malignancies
Interventions: Drug: Posaconazole;   Drug: ABLC

Study has passed its completion date and status has not been verified in more than two years.